Background: Identification of symptoms is challenging with surveys, which are time-intensive and low-throughput. Natural language processing (NLP) could be utilized to identify symptoms from narrative documentation in the electronic health record (EHR).
Significance Statement:
Patients on maintenance hemodialysis experience a high frequency of symptoms. However, symptoms have been measured utilizing time-intensive surveys. This paper compares natural language processing (NLP) to administrative codes for the identification of seven key symptoms from two cohorts with electronic health records and validation through manual chart review. NLP identified high rates of symptoms; the most common were fatigue, pain, and nausea and/or vomiting. A majority of patients had ≥ 4 symptoms. NLP was significantly more sensitive at identifying symptoms compared to administrative codes for nearly all symptoms but specificity was not significantly different compared to codes. This paper demonstrates utility of a high throughput method of identifying symptoms from EHR which may advance the field of patient centered research in nephrology.
We undertook this study to determine the ability of NLP to retrospectively identify symptoms in HD patients from the EHR. We then compared the performance of NLP and ICD identification against manual chart review.
Methods:

Study Population
From an original cohort of 38,575 participants from the Charles Bronfman Institute of We retrieved all clinical notes of BioMe Participants available from the centralized DataMart up to December 31, 2017. HD patients were identified as patients with ESRD nausea and/or vomiting, anxiety, and cramps, NLP identification in at least one note was considered as test positive. For depression, as the disease is more chronic in nature, NLP identification in at least two notes on at least two different dates was necessarily to be considered test positive. We performed two iterations of NLP parsing with manual chart review guiding the second iteration. We rectified errors in identification in the NLP engine prior to the execution of the final parsing. Examples included phrases such as "The patient was advised to call for any fever or for prolonged or severe pain or bleeding" and "EKG sinus tach with V4, V5 depressions". We modified the NLP algorithm to recognize these as negative expressions.
We report results in this manuscript from the final NLP query.
We compared performance of ICD-CM codes with the results obtained from CLiX NLP.
ICD-CM codes were chosen as described in prior literature when available and through physician extensive review of ICD-CM codes when not available. [10] [11] [12] ICD-9 and 10 codes were used in BioMe while only ICD-9 codes were available in MIMIC-III (Supplemental Table 3 ).
Finally, both methods were compared with independent chart review by two physicians (LC and KB). When there was disagreement between manual validations for a patient, joint review of the patient's chart was performed until consensus agreement was obtained.
As an additional validation of our NLP results, specifically for the depression query, we identified patients who had undergone Patient Health Questionnaire 9 (PHQ-9) screening since this is a common survey based instrument that is administered to dialysis patients. 13, 14 We considered depression screening positive if patients scored ≥ 10. If scores were <10 or there was discrepancy between depression as identified by PHQ-9, ICD, or NLP, additional manual chart review was done to identify evidence of history of depression (i.e. cognitive behavior therapy, anti-depressive medications, or prior suicide attempts). For patients with multiple PHQ-
Statistical Analyses:
We calculated sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and F1-score of NLP and ICD9/10 codes. For cells on the 2x2 table where the value was 0, we entered 0.5 to allow for calculation of test statistics. We compared estimates of sensitivity, specificity, and F1-score using the McNemar test with significance set using a two sided p value of <0.05. We compared NPV and PPV using the generalized score statistic. 15 All analyses were done using SAS version 9.4 (SAS Institute, Cary NC).
Results:
Patient Characteristics:
Out of 1152 patients with ESRD identified by the USRDS in BioMe, we identified 1034 (90%) patients receiving maintenance HD. These HD patients had a mean age of 63.6±13.3 years, 42% were women, and 42% self-reported as African American. As expected of HD patients, there was high prevalence of diabetes (51%), hypertension (85%), coronary artery disease (53%), and congestive heart failure (31%) ( Table 1 ). The median number of encounters was 109, (interquartile range [IQR] 41-241).
From MIMIC-III, we identified 929 HD patients utilizing ICD-9 codes. The mean age of patients was 67.4±37 years, 41% of patients were women, and 63% self-reported as white.
Prevalence rates of chronic co-morbidities were similarly high, diabetes (59%), hypertension (92%), coronary artery disease (49%), and congestive heart failure (57%) ( Table 1) . Encounter analysis could not be done in MIMIC-III as the database only included encounters with ICU stays and nearly 80% of patients had only one ICU admission.
Symptom Identification using NLP vs Administrative Codes:
In BioMe HD patients, NLP identified symptoms more frequently than did ICD-9 and 10 codes ( Figure 1A) . The most frequent symptoms identified were pain (NLP 93% vs. ICD 46%, P<0.001), fatigue (NLP 84% vs. ICD 41%, P<0.001), and nausea and/or vomiting (NLP 74% vs.
ICD 19%, P<0.001). The symptoms that were picked up best by both NLP and ICD were pain (45%), fatigue (40%), and depression (19%).
In the MIMIC-III cohort, again NLP identified symptoms more commonly than ICD-9
codes. ( Figure 1B) The symptoms with the highest prevalence according to NLP were pain (NLP 96% vs. ICD 6%, P=0.16), fatigue (NLP 70% vs. ICD 41%, P<0.001), and nausea and/or vomiting (NLP 63% vs. 19%, P <0.001). ICD-9 codes were best able to identify depression (17%) and no ICD-9 code for cramps was found in MIMIC-III.
Manual Chart Validation:
Overall, NLP was superior to ICD for identifying symptoms in both cohorts. In the BioMe dataset sensitivity for NLP ranged from 0.85 to 0.99 while sensitivity for ICD ranged from 0.09 to 0.59 for ICD. In the MIMIC-III dataset, sensitivity for NLP ranged from 0.8 to 0.98 while sensitivity for ICD ranged from 0.02 to 0.53. ( Twenty-five patients were identified by NLP to have undergone PHQ-9 depression screening. While 3 patients had PHQ-9 scores <10, 2 of the 3 had a clinical history of depression (active group therapy, inpatient psychiatric admissions for depression, or prior suicide attempts) but were receiving adequate treatments therefore resulting in low PHQ-9
scores. The last patient did not have evidence (ICD, NLP, or on chart review) of having depression. Of the 24 patients who were depression positive by PHQ-9 and/or clinical history, NLP correctly identified 22 (92%) patients while ICD 9/10 identified 20 (83%) patients.
Symptom Burden
In the BioMe cohort, symptom burden was high among HD patients. NLP, identified at least 1 symptoms in 96% of patients, and 4 or more symptoms in 50% of patients. (Figure 2A )
The number of symptoms identified increased with the number of encounters in BioMe. Patients who did not have any symptoms identified by NLP had a median of 7 encounters (IQR 1-32), while patients with all 7 symptoms had a median of 230 encounters (IQR 141-419). (Figure 3 )
In MIMIC-III, NLP identified at least 1 symptom in 97% of patients, and 4 or more symptoms in 48% of patients. (Figure 2B ) Encounter analysis could not be performed for MIMIC-III.
Discussion:
High-throughput retrospective assessment of symptoms in patients on HD from EHR is difficult. NLP is one potential solution to this problem. We demonstrated that NLP had better sensitivity than ICD codes at identifying seven symptoms with validation across two different cohorts. 3 The symptom burden was high, with a majority of patients having at least 4 or more symptoms. Finally, identification of symptoms was highly dependent on the number of encounters that HD patients had.
As the care of HD patients is improving, focus has shifted to improving how patients feel (i.e., patient centered outcomes). The SONG-HD initiative has identified several key outcomes important to all stakeholders (patients and physicians) and has emphasized the importance of clinical research that includes these symptoms as both predictors and outcomes. Prior research that employed patient-centered outcomes as endpoints have required prospective surveys for their execution. 2, 16 This is labor-intensive and only allows assessment of symptom burden at the time of the survey. By using NLP, notes can be processed in a high-throughput manner. In addition, benchmarking and reporting these patient-centered outcomes from multiple dialysis providers could provide a unique opportunity to improve clinical practice.
There are currently few studies in nephrology that have utilized NLP. The predominant use has been on the identification of risk factors for progression of chronic kidney disease and the identification of CKD from EHR. [17] [18] [19] [20] [21] [22] . Additionally, the studies that have utilized NLP to identify risk factors for progression of chronic kidney disease included few symptoms or patientcentered outcomes in their models. Prior studies in other chronic diseases, such as pancreatic cancer, have demonstrated the utility of NLP to identify the patient-centered outcomes of urinary incontinence and erectile dysfunction from EHR. 23 Our study supports the use of NLP for identification of patient-centered outcomes in HD patients given the higher sensitivity of the NLP method compared to identification with ICD codes.
We found that overall symptom prevalence identified in the BioMe cohort by NLP is similar to prior published survey data on symptoms, i.e. prevalence of fatigue was reported to be 69-87% in literature and we found a prevalence of 84%. 16, 24, 25 Certain symptoms were less commonly found such as itching (NLP 48% vs. literature 52-70%) and cramps (NLP 45% vs.
literature 43-74%), while other symptoms such as nausea and/or vomiting (NLP 74% vs literature 26-35%) were more commonly found. The differences are likely due to differences in cohorts and settings.
While surveys are done in patients who are stable at their outpatient hemodialysis centers, BioMe provider notes consist not only of preventative care visits, but also acute inpatient and outpatient notes where more severe symptoms are documented. As MIMIC-III consists of progress notes from hospital visits that required an ICU admission, symptoms were identified at an even lower rate. One potential reason is that patients admitted to ICUs are critically ill and potentially with altered mental status or mechanically ventilated which prevents patients from verbalizing their symptoms. Additionally, patient care and billing is often focused on the admission diagnosis and contributing comorbidities, while symptoms and psychosocial comorbidities may not be as well addressed in notes. We chose to not to place limitations on the number, timing, or type of notes, which may have increased the likelihood of NLP identifying a symptom. However, comparator measures via ICD 9/10 codes, were also identified without limitations to encounters, allowing for a fair comparison.
Despite these differences in cohorts, NLP was significantly more sensitive than ICD codes for identification of nearly all symptoms in both BioMe and MIMIC-III. ICD9/10 codes are commonly used for the identification of several disease processes from administrative data and we found that NLP out performed ICD 9/10 codes at identification of all symptoms in both BioMe and MIMIC-III. [26] [27] [28] [29] As ICD 9/10 codes are administrative codes clinicians may be less inclined to use them to document symptoms experienced by HD patients. When ICD codes for symptoms were present in our data, they identified symptoms with high specificity.
While NLP was more sensitive at identifying depression, ICD codes were more specific.
A substantial portion of the false positives for depression was due to the use of depression in other clinical contexts. As there was no consistent way that this was documented across notes it could not be easily addressed in our NLP algorithm.
Our study should be interpreted in light of some limitations of our study including the dependence of symptom identification on the number of encounters and notes available, the more encounters available the more likely a provider was to document a symptom. However, this is a common issue with EHR systems, where both sicker patients as well as patients with longer length of follow up having more data. 30 Additionally, only symptoms which the provider are screening for are documented and therefore NLP may miss those symptoms patients are not discussing with their providers. Neither the BioMe nor MIMIC-III datasets are exclusive to outpatient HD patients, which make comparison with prior published data on outpatient HD patients difficult. However, the prevalence of symptoms in our study is similar to prior published survey data. 24, 25 Unfortunately, as we did not have concurrent survey data available, we used manual chart review as our gold standard. We did extract PHQ-9 survey results to further validate our findings, however only a small portion of patients had this screening done.
Additionally, the results of our sensitivity, specificity, PPV, NPV, and F1 scores were relatively consistent across the BioMe and MIMIC-III cohort, suggesting that our NLP algorithm would have good generalizability across different medical systems.
In conclusion, we utilized NLP to identify important patient symptoms from EHR of HD patients from two diverse medical systems. Prevalence of symptoms identified by NLP was similar to previously published survey studies. NLP out performed ICD codes for identification in regards to sensitivity, NPV, and F1 score for a majority of symptoms in both cohorts. Additional refinement of the NLP algorithm and testing in the EHR of outpatient HD units is needed to further validate our findings. 
